ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 123 filers reported holding ANI PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $48,173,000 | +1.0% | 794,666 | +10.6% | 0.01% | -10.0% |
| Q3 2016 | $47,682,000 | +29.3% | 718,640 | +8.7% | 0.01% | +25.0% |
| Q2 2016 | $36,888,000 | +69.2% | 660,831 | +2.0% | 0.01% | +60.0% |
| Q1 2016 | $21,803,000 | -24.0% | 647,738 | +2.0% | 0.01% | -28.6% |
| Q4 2015 | $28,670,000 | +12.7% | 635,337 | -1.3% | 0.01% | 0.0% |
| Q3 2015 | $25,443,000 | -35.1% | 643,971 | +1.9% | 0.01% | -22.2% |
| Q2 2015 | $39,194,000 | +3.6% | 631,656 | +4.4% | 0.01% | 0.0% |
| Q1 2015 | $37,828,000 | +107.6% | 604,758 | +87.2% | 0.01% | +80.0% |
| Q4 2014 | $18,221,000 | +290.4% | 323,121 | +95.8% | 0.01% | +400.0% |
| Q3 2014 | $4,667,000 | -19.9% | 165,024 | -2.5% | 0.00% | -50.0% |
| Q2 2014 | $5,828,000 | – | 169,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |